Fig. 1From: Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference CenterGraph illustrating the number of patients referred to MGFT for genetic diagnosis of CYP21A2 from 2006 to July 2023. A total of 1222 patients with clinical suspicion of CAH have been tested since 2006, two-hundred and sixty-five (21.7%) were identified as heterozygous and 153 (12.5%) as compound heterozygous/homozygousBack to article page